Dose Response to Recombinant Factor VIIa When Administered for Bleed

Clinical trial NCT00104455 · COMPLETED

Trial details

NCT number: NCT00104455
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Congenital Bleeding Disorder Healthy

Start date: 2004-06-01
Primary completion: 2004-11-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.